```

[Federal Register Volume 76, Number 20 (Monday, January 31, 2011)]
[Notices]
[Page 5379]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-1999]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Clinical Laboratory Improvement Advisory Committee (CLIAC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

Times and Dates:
    9:15 a.m.-5 p.m., March 2, 2011
    8:30 a.m.-12:30 p.m., March 3, 2011

    Place: CDC, 1600 Clifton Road, NE., Tom Harkin Global 
Communications Center, Building 19, Room 232, Auditorium B, Atlanta, 
Georgia 30333.
    Online Registration Required: In order to expedite the security 
clearance process at the CDC Roybal Campus located on Clifton Road, all 
CLIAC attendees are required to register for the meeting online at 
least 14 days in advance at http://wwwn.cdc.gov/cliac/default.aspx by 
clicking the ``Register for a Meeting'' link and completing all forms 
according to the instructions given. Please complete all the required 
fields before submitting your registration and submit no later than 
February 16, 2011.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 100 people.
    Purpose: This Committee is charged with providing scientific and 
technical advice and guidance to the Secretary, Department of Health 
and Human Services; the Assistant Secretary for Health; the Director, 
CDC; the Commissioner, Food and Drug Administration (FDA); and the 
Administrator, Centers for Medicare and Medicaid Services (CMS), 
regarding the need for, and the nature of, revisions to the standards 
under which clinical laboratories are regulated; the impact on medical 
and laboratory practice of proposed revisions to the standards; and the 
modification of the standards to accommodate technological advances.
    Matters To Be Discussed: The agenda will include agency updates 
from CDC, CMS, and FDA; presentations and discussions addressing 
activities of the Coordinating Council on the Clinical Laboratory 
Workforce; the National Institutes of Health Genetic Test Registry 
design and responses from testing laboratories; current testing 
practices and oversight of cytogenetic and cytogenomic testing; ongoing 
studies evaluating laboratory practices; and strategies for developing 
evidence-based methods for laboratory medicine quality improvement.
    Agenda items are subject to change as priorities dictate.
    Providing Oral or Written Comments: It is the policy of CLIAC to 
accept written public comments and provide a brief period for oral 
public comments whenever possible.
    Oral Comments: In general, each individual or group requesting to 
make an oral presentation will be limited to a total time of five 
minutes (unless otherwise indicated). Speakers must also submit their 
comments in writing for inclusion in the meeting's Summary Report. To 
assure adequate time is scheduled for public comments, individuals or 
groups planning to make an oral presentation should, when possible, 
notify the contact person below at least one week prior to the meeting 
date.
    Written Comments: CLIAC accepts written comments until the date of 
the meeting (unless otherwise stated) for individuals or groups unable 
to attend the meeting. However, the comments should be received at 
least one week prior to the meeting date so that the comments may be 
made available to the Committee for their consideration and public 
distribution. Written comments and one hard copy with original 
signature should be provided to the contact person below. In addition, 
written comments will be included in the meeting's Summary Report.
    Contact Person for Additional Information: Nancy Anderson, Chief, 
Laboratory Practice Standards Branch, Division of Laboratory Science 
and Standards, Laboratory Science, Policy and Practice Program Office 
(LSPPPO), Office of Surveillance, Epidemiology and Laboratory Services, 
CDC, 1600 Clifton Road, NE., Mailstop F-11, Atlanta, Georgia 30333; 
telephone (404) 498-2741; fax (404) 498-2219; or via e-mail at 
[email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

    Dated: January 25, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-1999 Filed 1-28-11; 8:45 am]
BILLING CODE 4163-18-P
```